Cargando…
Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions
PURPOSE: The growing recognition of epilepsies and encephalopathies associated with autoantibodies against surface neuronal proteins (LGI1, NMDAR, CASPR2, GABA(B)R, and AMPAR) means that epileptologists are increasingly asking questions about mechanisms of antibody-mediated epileptogenesis, and abou...
Autores principales: | Bakpa, Ochuko D., Reuber, Markus, Irani, Sarosh R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042290/ https://www.ncbi.nlm.nih.gov/pubmed/27450643 http://dx.doi.org/10.1016/j.seizure.2016.07.002 |
Ejemplares similares
-
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, Ronan N, et al.
Publicado: (2021) -
Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology
por: Binks, Sophie, et al.
Publicado: (2020) -
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions
por: Varley, James, et al.
Publicado: (2014) -
Neuronal antibodies in pediatric epilepsy: Clinical features and long‐term outcomes of a historical cohort not treated with immunotherapy
por: Wright, Sukhvir, et al.
Publicado: (2016) -
The clinical features, underlying immunology, and treatment of autoantibody‐mediated movement disorders
por: Damato, Valentina, et al.
Publicado: (2018)